Position in MRK
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$3,514,989
-$616,371 QoQ
Shares Held
27,354
-20.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#1,239
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Archford Capital Strategies, LLC holds $29,267,302 across 10 Drug Manufacturers - General names. MRK ranks #3 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,636 | $10,320,324 | |
| 2 | NVS |
Novartis AG
|
49,908 | $7,821,581 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
27,354 | $3,514,989 | |
| 4 | LLY |
ELI LILLY & Co
|
2,586 | $3,101,726 | |
| 5 | ABBV |
AbbVie Inc.
|
6,013 | $1,513,111 | |
| 6 | SNY |
Sanofi
|
33,227 | $1,417,463 | |
| 7 | AZN |
Astrazeneca PLC
|
2,652 | $502,872 | |
| 8 | PFE |
Pfizer Inc
|
18,376 | $442,494 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,514,989 | 27,354 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $4,131,360 | 34,345 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,291,434 | 12,269 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,037,458 | 12,361 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $984,275 | 12,434 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,112,216 | 12,391 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,228,478 | 12,349 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,429,947 | 12,592 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,506,769 | 12,171 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,629,978 | 12,353 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,335,385 | 12,249 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,185,057 | 11,511 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,070,473 | 9,277 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $764,518 | 7,186 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $681,011 | 6,138 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $514,911 | 5,979 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $526,780 | 5,778 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $506,166 | 6,169 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $364,040 | 4,750 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $261,457 | 3,481 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $310,924 | 3,998 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $482,892 | 6,264 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $492,517 | 6,021 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $508,317 | 6,128 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $500,634 | 6,474 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $518,883 | 6,744 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||